Managed Account Advisors’s Lexicon Pharmaceuticals LXRX Stock Holding History

Managed Account Advisors’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$297K	Sell	36,837 -9,081	-20%	-$66.7K	﹤0.01%	2403
2015 Q1	$303K	Buy	45,918 +14,624	+47%	+$99.9K	﹤0.01%	2346
2014 Q4	$199K	Buy	31,294 +19,789	+172%	+$160K	﹤0.01%	2331
2014 Q3	$114K	Buy	11,505 +4,859	+73%	+$51.9K	﹤0.01%	2363
2014 Q2	$75K	Buy	6,646 +1,424	+27%	+$15.3K	﹤0.01%	2365
2014 Q1	$63K	Buy	5,222 +2,147	+70%	+$27.4K	﹤0.01%	2349
2013 Q4	$39K	Buy	3,075 +2,013	+190%	+$32K	﹤0.01%	2383
2013 Q3	$18K	Buy	1,062 +379	+55%	+$6.36K	﹤0.01%	2400
2013 Q2	$10K	Buy	+683	New	+$10.4K	﹤0.01%	2432

Other funds holding LXRX

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Masters Capital Management Atlanta, Georgia $677M AUM 57.21% 1-Year Est. Return

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return